Richard Scolyer Update 2026: Glioblastoma Surgery & Prognosis
Richard Scolyer’s experimental glioblastoma treatment initially defied expectations, yet his 2026 update reveals a more complex reality where tumor stability coexists with serious physical setbacks. The Australian pathologist who pioneered a world-first personalized immunotherapy now faces a recovery from emergency open heart surgery while his tumor area remains stable. Diagnosed: 2023 · Cancer type: Grade … Read more